Abstract
In the Original Article by Dikci et al. “The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/ Syndrome” (Endocr Metab Immune Disord Drug Targets. 2019; 19(2):166-170) after publication of the article it has come to the corresponding author's attention that there were some errors in the article. In the introduction section, reference 3 should be changed as reference 2 (paragraph 1, line 4) and references 4-6 should be changed as references 3-6 (paragraph 1, lines 6,7). Reference numbers in the references section should be as follows. References 25-28 should be changed as references 7-10 respectively. References 7-24 should be changed as references 11-28 respectively.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Corrigendum to: The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/Syndrome
Volume: 19 Issue: 5
Author(s): Seyhan Dikci*, Emrah Öztürk, Penpe Gül Fırat, Turgut Yılmaz, Mehmet Çağatay Taşkapan and Saim Yoloğlu
Affiliation:
- Inonu Universiy Turgut Ozal Medical Center, Department of Ophthalmology, Malatya,Turkey
Abstract: In the Original Article by Dikci et al. “The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/ Syndrome” (Endocr Metab Immune Disord Drug Targets. 2019; 19(2):166-170) after publication of the article it has come to the corresponding author's attention that there were some errors in the article. In the introduction section, reference 3 should be changed as reference 2 (paragraph 1, line 4) and references 4-6 should be changed as references 3-6 (paragraph 1, lines 6,7). Reference numbers in the references section should be as follows. References 25-28 should be changed as references 7-10 respectively. References 7-24 should be changed as references 11-28 respectively.
Export Options
About this article
Cite this article as:
Dikci Seyhan *, Öztürk Emrah , Fırat Gül Penpe , Yılmaz Turgut , Taşkapan Çağatay Mehmet and Yoloğlu Saim , Corrigendum to: The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/Syndrome, Endocrine, Metabolic & Immune Disorders - Drug Targets 2019; 19 (5) . https://dx.doi.org/10.2174/187153031905190701170237
DOI https://dx.doi.org/10.2174/187153031905190701170237 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Adipose-derived Mesenchymal Stem Cells in the Treatment of Obesity: A Systematic Review of Longitudinal Studies on Preclinical Evidence
Current Stem Cell Research & Therapy Sudden Infant Death Syndrome from Epidemiology to Pathophysiology
Current Pediatric Reviews Leptinaemia and Antiendothelial Antibodies in Accelerated Atherosclerosis – Is There a Relationship?
Vascular Disease Prevention (Discontinued) Structural Neuroimaging Findings in Major Depressive Disorder Throughout Aging: A Critical Systematic Review of Prospective Studies
CNS & Neurological Disorders - Drug Targets Editorial: Management of Diabetes in Unique Populations
Current Diabetes Reviews Structural Basis of Agonist Selectivity for Different nAChR Subtypes: Insights from Crystal Structures, Mutation Experiments and Molecular Simulations
Current Pharmaceutical Design Polycystic Ovary Syndrome: A Contemporary Clinical Approach
Current Pharmaceutical Design Aminergic Control and Modulation of Honeybee Behaviour
Current Neuropharmacology Small Molecule 11β- Hydroxysteroid Dehydrogenase Type 1 Inhibitors
Current Topics in Medicinal Chemistry The Current View on the Helicase Activity of RNA Helicase A and Its Role in Gene Expression
Current Protein & Peptide Science Development of Inhibitors of the Aspartyl Protease Renin for the Treatment of Hypertension
Current Protein & Peptide Science Treatment of Diabetic Foot Ulcer: An Overview Strategies for Clinical Approach
Current Diabetes Reviews Arginyl Aminopeptidase-Like 1 (RNPEPL1) Is an Alternatively Processed Aminopeptidase with Specificity for Methionine, Glutamine, and Citrulline Residues
Protein & Peptide Letters Rare Genetic Diseases with Human Lean and/or Starvation Phenotype Open New Avenues for Obesity and Type II Diabetes Treatment
Current Pharmaceutical Biotechnology CART Peptides Regulate Psychostimulants and May be Endogenous Antidepressants
Current Neuropharmacology Insulin Resistance is Associated with Clinical Manifestations of Diabetic Kidney Disease (Glomerular Hyperfiltration, Albuminuria, and Kidney Function Decline)
Current Diabetes Reviews Methodologies for Investigating Natural Medicines for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
Current Pharmaceutical Biotechnology The β 2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB- 231 Cell Line
Current Cancer Drug Targets Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases
Current Medicinal Chemistry Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Current Neuropharmacology